Probiotics: Food Supplement for Human Consumption
Journal of Scientific Research and Reports,
The human gut microflora contains 1000 of dynamic microbial ecosystem to maintain balance between immune boosting and harmful bacteria. The good bacteria reside in healthy human gut and responsible for increasing energy production, inhibiting pathogenic growth. In unhealthy gut microbiota initiates the development of disorders in human body include metabolic disorder, chronic diarrhea, obesity. The article deals with the study of emerging trends in probiotics and developing industrial probiotics products for human body. At present there are many probiotics foodstuff isolated by industries from natural foods includes vegetables, grain, cereals to use in the form of nutrient supplements. Human Gut can be enriched with natural, low cost Probiotic supplements to improve lifestyle.
- Gut microflora
- metabolic disorder
- immune boosting
How to Cite
Sanders ME, Merenstein DJ, Ouwehand AC, Reid G, Salminen S, Cabana MD, et al. Probiotic usein at-risk populations. J Am Pharm AssocJAPhA. 2016;56(6):680–6.
Lau CS, Chamberlain RS. Probiotics are effective at preventing Clostridium difficile-associateddiarrhea: A systematic review and meta-analysis. Int J Gen Med. 2016;22(9):27–37.
Hamad A, Fragkos KC, Forbes A. A systematic review and meta-analysis of probiotics for the management of radiation induced bowel disease. Clin Nutr Edinb Scotl. 2013;32(3):353–60.
Dang Y, Reinhardt JD, Zhou X, Zhang G. The effect of probiotics supplementation on Helicobacter pylori eradication rates and side effects during eradication therapy: A meta-analysis. PloS One. 2014;9(11):e111030.
Bindels LB, Delzenne NM, Cani PD, Walter J. Towards a more comprehensive concept for prebiotics. Nat Rev Gastroenterol Hepatol 2015;12:303–10.
Floch MH, Walker WA, Sanders ME, Nieuwdorp M, Kim AS, Brenner DA, et al. Recommendations for probiotic use — 2015 update: Proceedings and consensus opinion. J ClinGastroenterol. 2015;49(Suppl 1):S69–73.
Gibson GR, Roberfroid MB. Dietary modulation of the colonic microbiota: Introducing the concept ofprebiotics. J Nutr. 1995;125:1401–12.
Goldenberg JZ, Ma SS, Saxton JD, Martzen MR, Vandvik PO, Thorlund K, et al. Probiotics for the prevention of Clostridium difficile–associated diarrhea in adults and children. Cochrane DatabaseSyst Rev. 2013;CD006095.
DOI: 10.1002/14651858.CD006095.pub3 PubMed PMID: 23728658.
Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scopeand appropriate use of the term probiotic. Nat Rev GastroenterolHepatol. 2014;11:506–14.
Du YQ, Su T, Fan JG, Lu YX, Zheng P, Li XH, et al. Adjuvant probiotics improve the eradication effect of triple therapy for Helicobacter pylori infection. World J Gastroenterol. 2012;18(43):6302–7.
Bekar O, Yilmaz Y, Gulten M. Kefir improves the efficacy and tolerability of triple therapy in eradicating Helicobacter pylori. J Med Food. 2011;14(4):344–7.
Tong JL, Ran ZH, Shen J, Zhang CX, Xiao SD. Meta-analysis: The effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy. Aliment PharmacolTher. 2007;25(2):155–68.
Francavilla R, Polimeno L, Demichina A, Maurogiovanni G, Principi B, Scaccianoce G, et al. Lactobacillus reuteri strain combination in Helicobacter pylori infection: A randomized, doubleblind, placebo-controlled study. J ClinGastroenterol. 2014;48(5):407–13.
Emara MH, Mohamed SY, Abdel-Aziz HR. Lactobacillus reuteri in management of Helicobacter pylori infection in dyspeptic patients: A double-blind placebo-controlled randomized clinical trial. Ther Adv Gastroenterol. 2014;7(1): 4–13.
Hungin AP, Mulligan C, Pot B, Whorwell P, Agréus L, Fracasso P, et al. Systematic review: Probioticsin the management of lower gastrointestinal symptoms in clinical practice — an evidence-basedinternational guide. Aliment PharmacolTher. 2013;38:864–86.
Kobyliak N, Conte C, Cammarota G, Haley AP, Styriak I, Gaspar L, et al. Probiotics in prevention and treatment of obesity: A critical view. Nutr Metab. 2016;1-13.
Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J Nutr. 1995;125:1401-1412.
Hamasalim HJ. Synbiotic as feed additives relating to animal health and performance Adv Microbiol. 2016;6:288-302.
Bongaerts GPA, Severijnen RSVM. A reassessment of the PROPATRIA study and its implications for probiotic therapy. Nature Biotechnol. 2016;34;55-63.
Patel RM, Denning PW. Therapeutic use of prebiotics, probiotics, and postbiotics to prevent necrotizing enterocolitis: what is the current evidence? Clin Perinatol. 2013;40:11-25.
Islam SU. Clinical uses of probioticsMedicine (Baltimore). 2016;95:1-5.
Ooi MF, Mazlan N, Foo HL, Loh TC, Mohamad R, Rahim RA, et al. Effects of carbon and nitrogen sources on bacteriocin-inhibitory activity of postbiotic metabolites produced by Lactobacillus plantarum I-UL4Malays J Microbiol. 2015;11:176-184.
Ambalam P, Raman M, Purama RK, Doble M. Probiotics, prebiotics and colorectal cancer prevention. Best Pract. Res. Clin. Gastroenterol. 2016;30:119–131.
Bautista-Gallego J, Ferrocino I, Botta C, Ercolini D, Cocolin L, Rantsiou K. Probiotic potential of aLactobacillusrhamnosuscheese isolate and its effect on the fecal microbiota of healthy volunteers. Food Res. Int. 2019;119:305–314.
Tarrah A, de Castilhos J, Rossi RC, da Duarte VS, Ziegler DR, Corich V, Giacomini A. In vitro probiotic potential and anti-cancer activity of newly isolated folate-producing Streptococcus thermophilus strains. Front. Microbiol. 2018;9:2214.
Bermúdez-Humarán LG, Salinas E, Ortiz GG, Ramirez-Jirano LJ, Morales JA, Bitzer-Quintero OK. From probiotics to psychobiotics: live beneficial bacteria which act on the brain-gut axis. Nutrients. 2019;11:890.
Cicenia A, Scirocco M, Carabotti L, Pallotta M, Marignani C. Severi postbiotic activities of lactobacilli-derived factorsJClinGastroenterol. 2014;48:S18-S22.
Gibson GR, Hutkins R, Sanders ML, Prescott SL, Reimer RA, Salminen SJ, et al. The international scientific association for probiotics and prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017;14:491-502.
Kano M, Masuoka N, Kaga C, Sugimoto S, Iizuka R, Manabe K, et al. Consecutive intake of fermented milk containing Bifidobacteribreve strain Yakult and galacto-oligosaccharides benefits skin condition in healthy adult womenBiosci Microbiota Food Health. 2013;32:33-39.
Nomoto K. Prevention of infections by probiotics,J. Bio-sci. Bioeng. 2005;100:583–592.
Maldonado Galdeano C, de Moreno de LeBlanc A, Carmuega E, Weill R, Perdigón G. Mechanisms involved intheimmunostimulation by probiotic fermented milk. J.Dairy Res. 2009;76:446–454.
Medina M, Izquierdo E, Ennahar S, Sanz Y. Differentialimmunomodulatory properties ofBifidobacteriumlogumstrains: Relevance to probiotic selection and clinical app-lications,Clin. Exp. Immunol. 2007;531–538.
Kelly D, Campbell JI, King TP, Grant G, Jansson EA, Couttset AG, et al. Commensal anaerobic gut bacteria atte-nuate inflammation by regulating nuclear-cytoplasmicshuttling of PPAR-gandRelA,Nat. Immunol. 2004;5:104–112.
Arunachalam K, Gill HS, Chandra RK. Enhancement ofnatural immune function by dietary consumption ofBifido-bacterium lactis(HN019),Eur. J. Clin. Nutr. 2000;54:263–267.
Chiang BL, Sheih YH, Wang LH, Liao CK, Gill HS. Enhancing immunity by dietary consumption of a pro-biotic lactic acid bacterium (Bifidobacterium lactisHN019): Optimization and definition of cellular immune re-sponses,Eur. J. Clin. Nutr. 2000;54849–855.
Gill HS, Rutherfurd KJ, Prasad J, Gopal PK. Enhance-ment of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and bifidobacterium lactis (HN019), Br. J. Nutr. 2000;83:167–176.
Shu Q, Gill HS. A dietary probiotic (Bifidobacterium lactisHN019) reduces the severity ofEscherichia coliO157: H7infection in mice, Med. Microbiol. Immunol. 2001;189:147–152.
Peiren J, Buyse J, De Vos P, Lang E, Clermont D, et al. Improvingsurvival and storage stability of bacteria recalcitrant to freeze-drying: acoordinated study by European culture collections. ApplMicrobiolBiotechnol. 2015;99:3559-3571.
Champagne CP, Gardner NJ, Roy D. Challenges in the addition ofprobiotic cultures to foods. Crit Rev Food SciNutr. 2005;45:61-84.
Eric Banan-MwineDaliri, Fred Kwame Ofosu, Chen Xiuqin, Ramachandran Chelliah, Deog-Hwan Oh*. Probiotic effector compounds: Current knowledge and future perspectives front microbiol. 2021;12:655705.
Tolulope Joshua. AshaoluImmune boosting functional foods and their mechanisms: A critical evaluation of probiotics and prebiotics. 2020;130:110625.
Mohamed Zommiti , Marc GJ. Feuilloley and nathalie connil. Update of Probiotics in Human World: A Nonstop Source of Benefactions till the End of Time Microorganisms. 2020;8:1907.
Neel Jayesh Shah, *Onkar C Swami. Role of Probiotics in Diabetes: A review of their rationale and efficacyemj diabet. 2017;5:104-110.
Bathal Vijaya Kumar, :Sistla Venkata Naga Vijayendra, Obulam Vijaya Sarathi. Reddy trends in dairy and non-dairy probiotic products -a review. Journal of Food Science and Technology –Mysore. 2015;52(10).
Gibson GR, Walton GE. Impact of high fat diets, prebiotics and probiotics on gut microbiota and immune function, with relevance to elderly populations. Nutrition and Aging. 2015;3(2-4):171-92.
Zhang MM, Cheng JQ, Lu YR, Yi ZH, Yang P, Wu XT. Use of pre-, pro-and synbiotics in patients with acute pancreatitis: a meta-analysis. World J Gastroenterol: WJG. 2010;16(31):3970.
Olson D, Aryana K. An excessively high Lactobacillus acidophilusinoculation level in yogurt lowers product quality during storage. FoodSciNutr. 2008;41:911-918.
Jacobs S, Verbeke W, Sas B. Mode of delivery of probioticsConsumers’ preference and its determinants. Agro food Industry Hi Tech. 2014;256.
Champagne CP, Ross RP, Saarela M, Hansen KF, Charalampopoulos D. Recommendations for the viability assessment of probiotics asconcentrated cultures and in food matrices. Int J Food Microbiol. 2011;149:185-193.
Kozubsky L, et al. Lactobacillus johnsonii La1 antagonizes giardiaintestinalis In vivo. Infect Immun. 2005;73:1265-9.
Ivey KL, Lewis JR, Hodgson JM. Association between yogurt, milk, cheese consumption and common carotid artery intima-media thicknessand cardiovascular disease risk factors in elderly women. Am J Clin Nutr. 2011;94(1):2349.
Jaeger SR. Non-sensory factors in sensory science research. Food Qual Prefer. 2006;17(1-2):132- 144
Johnson MS, Jumbo Lucioni P, Watts AJ, Allison DB, Nagy TR. Effect of dairy supplementation on body composition andinsulinresistance in mice. Nutr. 2007;23(1112):83643.
Kiessling G, Schneider J, Jahreis G. Long term consumptionoffermented dairy products over 6 months increases HDLcholesterol.Eur J Clin Nutr. 2002;56(9):843-9.
Kumar M, Kumar R, Poovai PD, Kalaichelvan PT. Probiotics andmultitude of health benefits. J Res Bio. 2012;2:102-13
Caro DS, Tao H, Grillo A, Elia C, Gasbarrini G, Sepulveda AR, Gasbarrini A. Effects of Lactobacillus GG on genes expression pattern in small bowel mucosa. Dig Liver Dis. 2005;37:320–332.
Chen JJ, Wang R, Li XF, Wang RL. Bifidobacteriumlongum supplementation improved high-fat-fed-induced metabolic syndrome and promoted intestinal Reg-I gene expression. Exp Biol Med. 2011;236:823–831.
Collins JK, Thornton G, Sulliva GO. Selection of probiotic strains for human application. Int Dairy J . 1998;8:487–490.
Conly JM, Stein K, Worobetz L, Rutledge-Harding S. The contribution of vitamin K2 (metaquinones) produced by the intestinal microflora to human nutritional requirements for vitamin K. Am J Gastroenterol. 1994;89:915–923.
Dambekodi PC, Gilliland SE. Incorporation of cholesterol into the cellular membrane of Bifidobacteriumlongum. J Dairy Sci. 1998;81:1818–1824.
Delzenne N, Reid G. No causal link between obesity and probiotics. Nat Rev Microbiol. 2009;7:901.
Delzenne NM, NeyrinckAM, Ba¨ckhed F, CaniPD. Targeting gut microbiota in obesity: Effects of prebiotics and probiotics. Nat Rev Endocrinol. 2011;7:639–646.
Desjardins ML, Roy D. Growth of bifidobacteria and their enzyme profiles. J Dairy Sci. 1990;73:299–307.
Donkor ON, Henriksson A, Vasiljevic T, Shah NP. Rheological properties and sensory characteristics of set-type soy yogurt. J Agric Food Chem. 2007;55:9868–9876.
Nagpal R, Yadav H, Puniya AK, Singh K, Jain S, Marotta F. Potential of probiotics and prebiotics for synbiotic functional dairy foods. Int J Probiotics Prebiotics. 2007;2:75–84.
Nagpal R, Kumar A, Arora S. In-vitro probiotic potential of lactobacilli from indigenous milk products. Int J Probiotics Prebiotics. 2010;5:103–110.
Nagpal R, Behare PV, Kumar M, et al.Milk, milk products and disease free health: An updated overview. Crit Rev Food Sci Nutr. 2011;99999:1549–7852.
Naito E, Yoshida Y, Makino K, Kounoshi Y, Kunihiro S, Takahashi R, Matsuzaki T, Miyazaki K, Ishikawa F. Beneficial effect of oral administration of Lactobacillus casei strain Shirota on insulin resistance in diet-induced obesity mice. J ApplMicrobiol. 2011;110:650–657.
Chaafsma G. State of art concerning probiotic strains in milk prod-ucts. IDF Nutr News Lett. 1996;5:23–4.21.
Molin G. Probiotics in foods not containing milk or milk con-stituents, with special reference to Lactobacillos planturum 299v. Am J ClinNutr. 2001;73(suppl):380S–5S.22.
Sekine K, Toida T, Saito M, Kuboyama M, Kawashima T. A new morphologically characterized cell wall preparation (whole peptido-glycan) from Bifidobacterium infantis with a higher efficacy on the regression of an established tumor in mice. Cancer Res. 1985;45:1300–7.23.
Farmer RE, Shahani KM, Reddy GV. Inhibitory effect of yoghurt components upon the proliferation of ascites tumor cells. J DairySci. 1987;58:787–8.24.
Guidelines and criteria for evaluation of efficacy, safety and health claim of probiotic in food products in India. ILSI, India.
[Cited Sep 2012].
Balaji R Raja1, Kantha D Arunachalam. Market potential for probiotic nutritional supplements in India African Journal of Business Management. 2011;5(14):5418-5423,
Kurt Fenster,1 Barbara Freeburg,1 Chris Hollard,1 Connie Wong,1 Rune Rønhave Laursen,2 Arthur C Ouwehand3,* The production and delivery of probiotics: A review of a practical approach. Microorganisms. 2019;7(3):83.
Steward-Tull DES. The immunological activities of bacterial pepti-doglycans. Ann Rev Microbiol. 1980;34:311–40.25.
Okutomi T, Inagawa H, Nishizawa T, Oshima H, Soma GI, MizunoDI. Priming effect of orally administered muramy ldipeptide on induction of endogenous tumor necrosis factor. J BiolResponseMod. 1990;9:564–9.26.
Abstract View: 18 times
PDF Download: 7 times